374 related articles for article (PubMed ID: 7680984)
41. Pathophysiology and management of insomnia during depression.
Kupfer DJ
Ann Clin Psychiatry; 1999 Dec; 11(4):267-76. PubMed ID: 10596741
[TBL] [Abstract][Full Text] [Related]
42. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
Najib J
Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
[TBL] [Abstract][Full Text] [Related]
43. Treatment of primary insomnia.
Montplaisir J
CMAJ; 2000 Aug; 163(4):389-91. PubMed ID: 10976252
[No Abstract] [Full Text] [Related]
44. Benefit-risk assessment of zaleplon in the treatment of insomnia.
Barbera J; Shapiro C
Drug Saf; 2005; 28(4):301-18. PubMed ID: 15783240
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of insomnia in children: pharmacological aspects].
Idiazábal Alecha MA; Estivill Sancho E
An Pediatr (Barc); 2003 Sep; 59(3):239-45. PubMed ID: 12975116
[TBL] [Abstract][Full Text] [Related]
46. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
Soldatos CR; Dikeos DG; Whitehead A
Int Clin Psychopharmacol; 1999 Sep; 14(5):287-303. PubMed ID: 10529072
[TBL] [Abstract][Full Text] [Related]
47. [Loprazolam: a new imidazobenzodiazepine for the treatment of insomnia].
Pallarés M
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(1):49-52. PubMed ID: 2566256
[TBL] [Abstract][Full Text] [Related]
48. Hypnotic drugs for 1984.
Oswald I
Psychopharmacology Suppl; 1984; 1():84-90. PubMed ID: 6147844
[TBL] [Abstract][Full Text] [Related]
49. Issues in the use of benzodiazepine therapy.
Roth T; Roehrs TA
J Clin Psychiatry; 1992 Jun; 53 Suppl():14-8. PubMed ID: 1613014
[TBL] [Abstract][Full Text] [Related]
50. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
Holm KJ; Goa KL
Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
[TBL] [Abstract][Full Text] [Related]
51. Pharmacotherapy of insomnia: practice and prospects.
Dingemanse J
Pharm World Sci; 1995 May; 17(3):67-75. PubMed ID: 7550052
[TBL] [Abstract][Full Text] [Related]
52. [Clinical aspects of hypnotics].
Leutner V
Wien Med Wochenschr; 1989 Jun; 139(11):274-9. PubMed ID: 2569791
[TBL] [Abstract][Full Text] [Related]
53. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?
Lader MH
Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S399-405. PubMed ID: 10622686
[TBL] [Abstract][Full Text] [Related]
54. [Treatment of insomnia].
Syvälahti E
Duodecim; 1986; 102(22):1700-8. PubMed ID: 2879720
[No Abstract] [Full Text] [Related]
55. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics?
Hohagen F; Montero RF; Weiss E; Lis S; Schönbrunn E; Dressing H; Riemann D; Berger M
Eur Arch Psychiatry Clin Neurosci; 1994; 244(2):65-72. PubMed ID: 7948056
[TBL] [Abstract][Full Text] [Related]
56. Criteria for selection of appropriate benzodiazepine hypnotic therapy.
Mendels J
J Clin Psychiatry; 1991 Sep; 52 Suppl():42-6. PubMed ID: 1680126
[TBL] [Abstract][Full Text] [Related]
57. Insomnia. Diagnosis and management.
Grunstein R
Aust Fam Physician; 2002 Nov; 31(11):995-1000. PubMed ID: 12471955
[TBL] [Abstract][Full Text] [Related]
58. Sleep studies and rebound insomnia: methodological problems, laboratory findings, and clinical implications.
Lader M; Lawson C
Clin Neuropharmacol; 1987 Aug; 10(4):291-312. PubMed ID: 2902919
[No Abstract] [Full Text] [Related]
59. Drug treatment of insomnia: indications and complications.
Syvälahti EK
Ann Clin Res; 1985; 17(5):265-72. PubMed ID: 3909922
[TBL] [Abstract][Full Text] [Related]
60. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
